About Us
COMPANY HISTORY
Stemedica Cell Technologies, Inc. was founded as the result of a personal commitment by Executive Chairman Roger Howe and CEO Maynard Howe to find alternative therapy for a family member who had been left paralyzed from an automobile accident and whose recovery through stem cell therapy provided the impetus for establishing Stemedica.
The Company was formally incorporated in 2005 by a group of prominent scientists, leading clinicians, experienced investors and executives from successful medical, biotechnology and pharmaceutical businesses. Stemedica is a specialty biopharmaceutical company that is committed to the development and manufacture of best-in-class adult stem cells for use by approved research institutions and hospitals for pre-clinical and clinical studies.
Within the United States, the Company is currently developing regulatory
pathways for traumatic brain injury and wound repair. Outside the United
States, Stemedica provides its adult stem cells to hospitals and research
centers that are conducting studies under protocols approved by the appropriate
regulatory agencies. These studies are focused on the treatment of neurodegenerative
disease, sight restoration and wound repair.